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Abstract
Following influenza infection, natural killer (NK) cells function as interim effectors by suppressing viral replication until CD8 T
cells are activated, proliferate, and are mobilized within the respiratory tract. Thus, NK cells are an important first line of
defense against influenza virus. Here, in a murine model of influenza, we show that virally-induced IL-15 facilitates the
trafficking of NK cells into the lung airways. Blocking IL-15 delays NK cell entry to the site of infection and results in a
disregulated control of early viral replication. By the same principle, viral control by NK cells can be therapeutically enhanced
via intranasal administration of exogenous IL-15 in the early days post influenza infection. In addition to controlling early
viral replication, this IL-15-induced mobilization of NK cells to the lung airways has important downstream consequences on
adaptive responses. Primarily, depletion of responding NK1.1+ NK cells is associated with reduced immigration of influenza-
specific CD8 T cells to the site of infection. Together this work suggests that local deposits of IL-15 in the lung airways
regulate the coordinated innate and adaptive immune responses to influenza infection and may represent an important
point of immune intervention.
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Introduction
Influenza virus is a major human pathogen that causes
substantial morbidity and mortality—approximately 36,000
deaths annually in the United States alone [1]. Combined with
the severe economic burden imposed from seasonal influenza
outbreaks and growing concerns over potential imminent influen-
za pandemics, there is considerable need for a firm understanding
of the disease pathology, prevention strategies, and mechanisms of
host defense against the virus [2].
Influenza virus is primarily transmitted via inhaled aerosols and
results in an infection localized to the upper respiratory tract, with
viral replication largely limited to epithelial cells [3]. Mechanisms
by which the immune system eliminates influenza have been well
studied and are known to involve the coordinated actions of the
innate and adaptive immune systems. Namely, the cytolytic action
of influenza-specific CD8 T cells has been shown to be the primary
mediator of complete viral clearance, but important roles have also
been described for CD4 T cells [4,5,6]. In addition to T cells, a
crucial role has also been established for innate immune effectors
including natural killer (NK) cells, which provide short-term
control of viral replication prior to T cell activation [7]. NK cells
become activated following the loss of inhibitory signals coupled
with positive activating signals resulting in direct (via release of
cytotoxic granules and interferon c) or indirect (via activation of
macrophages and dendritic cells) target cell lysis [8]. NK cells are
vital in limiting influenza viral replication as depletion of NK cells
dramatically increases morbidity and mortality in hamsters and
mice [9], and in humans severe infections with the 2009 pandemic
H1N1 virus positively correlated with reduced numbers of NK
cells in the lungs [10]. Studies have indicated that the natural
cytotoxicity receptors NKp44 and NKp46, which recognize
hemagglutinin proteins of several different influenza strains
[11,12] is one mechanism used by NK cells to protect against
lethal viral challenge [13]. Secondarily, NK cells also aid in viral
clearance indirectly through the production and secretion of
cytokines which both amplifies local inflammation and recruits
antigen-specific CD8 T cells to sites of inflammation [14]. Implicit
in both of these functions is the ability of NK cells to accumulate
within the respiratory tract to contact infected cells and provide a
source of chemotactic signals to recruit recently activated CD8 T
cells.
Type I IFNs expressed within hours after viral infection have
been documented to induce expression of the chemokines CXCL9
and 10 which function to recruit CXCR3 expressing NK cells to
sites of infection [15]. However, Type I IFNs also modulate the
expression of the common gamma chain cytokine interleukin 15
(IL-15) [16,17,18], which we recently reported to be temporally
and locally increased following influenza infection [19]. This
expression of IL-15 in the respiratory tract facilitates the
recruitment of antigen-specific CD8 T cells to the respiratory
tract. However, it is unclear whether the chemotactic properties of
IL-15 uniquely affect migratory CD8 T cells or could be extended
to other IL-15-sensitive immune cells. NK and NKT cells are
nearly absent in IL-15
2/2 animals [20], highlighting the
important role of IL-15 on NK cell development and homeostasis
in the steady-state. Following viral infections, de novo production
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of NK cells [21,22], and transient systemic stimulation of NK cells
with soluble IL-15/IL-15Ra complexes also results in an
accumulation of phenotypically and functionally mature NK cells
[23,24]. In addition to these roles, IL-15 also can stimulate the
migration of NK cells in vitro and enhances their adhesion to
cultured endothelial cells [25]. We therefore hypothesized that
virally induced IL-15 functionally assists in the migration of NK
cells into the lung airways. We show here that an IL-15 deficiency
results in a site-specific reduction in NK cells from the lung airway
and an exacerbation of viral load at early time points post
influenza infection. Additionally, exogenous IL-15 induces the
specific migration of NK cells in vitro and in vivo. This IL-15-
dependent enhanced mobilization of NK cells to the lung airways
correlates with decreased viral loads. Importantly, in the absence
of NK cells, antigen-specific CD8 T cells fail to accumulate at the
site of infection, providing a possible link between IL-15-mediated
migratory effects of both the innate and adaptive immune
responses to influenza infection and suggest therapeutic possibil-
ities regarding the use of IL-15 to simultaneously regulate both
arms of the immune system for improved responses to viral
infection.
Materials and Methods
Ethics Statement
All animals were handled in strict accordance with good animal
practice as defined by the American Association for Accreditation
of Laboratory Animal Care as well as federal and state agencies.
All animal work presented here was approved by Institutional
Animal Care and Use Committee of University of Georgia (AUP
No. A2009-6-114).
Mice, Viruses, IL-15 Blocking, and NK Cell Depletion
C57BL/6 mice were purchased from Charles River (Wilming-
ton, MA) through the NCI program. Influenza A/HK-x31 (x31,
H3N2) was generously donated by Dr. S. Mark Tompkins
(University of Georgia, Athens, GA). Animals were infected
intranasally (i.n.) with 10
3 PFU HKx31 diluted in 50 mL sterile
PBS. IL-15 was blocked using 25 mg anti-IL-15 mAb (clone AIO3)
(eBioscience, San Diego, CA) administered daily via intraperito-
neal injection (i.p.) in 200 mL sterile PBS. IL-15 depletion was
confirmed by reductions in frequencies of both NK and CD44
hi
CD8
+ T cell in antibody-treated animals compared to untreated
animals 7 days after the initiation of mAb treatment. NK1.1+ cells
were depleted via intravenous (i.v.) injections of 200 uL PBS
containing 200 mg anti-NK1.1/mouse (clone PK136) every other
day (UCSF monoclonal antibody core facility, San Francisco, CA),
and depletion of NK cells was verified using an anti-NKp46 mAb
(Clone 21A9.4, eBioscience) throughout the experiment and 2
days after the last injection of the NK1.1 depleting mAb.
Tissue Preparation and Flow Cytometry
Lung airway-resident cells were harvested by bronchioalveolar
lavage (BAL) with 3 consecutive washes of 1 mL PBS. To isolate
cells from the lung parenchyma, lungs were perfused with
,25 mL PBS/heparin sodium solution, harvested, minced and
incubated at 37uC for 30 minutes in 1.25 mM EDTA. The tissue
was subsequently incubated in collagenase diluted in RPMI
(6 mg/mL) at 37uC for 1 hour and passed through a 5 mm cell
strainer. Isolated cells were subjected to separation via density
gradient centrifugation by resuspending cells in 47% Percoll
underlain with 67% Percoll. The gradients were then centrifuged
at 2800 rpm for 20 minutes, and lymphocytes at the interface
were collected. Spleen and lymph nodes were harvested from
animals, homogenized, and then passed through a cell strainer.
Spleen homogenate was depleted of erythrocytes by incubation in
tris-buffered ammonium chloride.
Single cell suspensions were stained with combinations of
cocktails containing anti-CD3, NK1.1, NKp46, CD11c, CD11b,
CD122, and CD132 (eBioscience, San Diego, CA) as indicated for
20 minutes at 4uC. Where indicated, cells were concurrently
stained with or without biotinylated anti-IL-15Ra (R&D Systems,
Minneapolis, MN) followed by 20 minute incubation with APC-
conjugated Streptavidin at 4uC. Influenza nuclear protein (NP)
MHC class I tetramer [H2-D
b/ASNENMETM] were generated
by the National Institute of Allergy and Infectious Diseases
Tetramer Facility (Emory University, Atlanta, GA). Tetramer
staining was conducted at room temperature for 1 hour concur-
rently with anti-CD3, NK1.1, NKp46, CD8, and CD44
(eBioscience, San Diego, CA). Stained cells were analyzed using
a BD LSRII digital flow cytometer (BD Biosciences, San Jose, CA)
and either BD FACSDiva or FlowJo software (Tree Star, Inc.,
Ashland, OR).
Migration and Proliferation Assays
IL-15 complexes (IL-15c) were generated on the day of use by
incubating 1.5 mg recombinant mIL-15 with 7 mg IL-15Ra Fc-
chimera (R&D Systems, Minneapolis, MN) at 37uC for 20 min-
utes followed by 4uC for at least 10 minutes. For Ra only controls,
7 mg IL-15Ra Fc-chimera (R&D Systems, Minneapolis, MN) was
incubated similarly to complexes without addition of the cytokine.
Complexes or Ra alone were administered via passive inhalation
into both nostrils using a micropipette delivering 36.25 mL (for
daily treatments) or 72.5 mL (for one time treatments) of
complexes in sterile PBS. For assessment of cell proliferation,
animals received 2 mg of BrdU (Sigma-Aldrich, St. Louis, MO)
administered i.p. in a 200 mL volume of PBS. Cells were isolated
from these animals 12 hours after treatment and stained with
20 mL aminoactinomycin D (7-AAD; BD Pharmingen, San Jose,
CA) for 20 minutes at 4uC. Cells were surface stained as previously
described and stained intracellularly with FITC-labeled anti-Ki-67
and APC-labeled anti-BrdU monoclonal antibodies (BD Pharmin-
gen, San Jose, CA) according to manufacturer’s instructions.
In vitro migration assays were performed by placing bulk
populations of lymphocytes containing predetermined numbers of
NK cells (verified by FACs analysis) from the indicated tissues on
the top insert of a 5 mm chemotaxis transwell (Fisher Scientific,
Waltham, MA) in which the bottom well contained warm media
alone or supplemented with 100 ng/mL IL-15c. IL-15c was
generated by incubating 100 ng of IL-15 with 500 ng IL-15Ra Fc-
chimeric protein at 37u for 20 minutes and 4u for 10 minutes.
Plates containing transwells were then incubated at 37uC with
CO2 exchange, and 90 minutes after plating, cells were harvested
from bottom chambers and the percent migration of NK cells was
calculated as the ratio of the number of NK cells in the bottom
chamber compared to the number of NK cells determined in the
input sample.
Plaque Assays
Plaque assays were preformed as previously described [26].
Briefly, lungs from HK-x31 infected animals were collected and
homogenized using a tissue lyser (Qiagen, Hilden, Germany).
Monolayers of Madin-Darby kidney cells were incubated with 10-
fold serial dilutions of 10% homogenate in dilution media
(16MEM, 1 mg/mL TPCK-treated trypsin) for 1 hour at 37uC.
Cells were washed with 16 sterile PBS and overlaid with MEM
containing 1.2% Avicel microcrystalline cellulose (FMC BioPoly-
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0.15% NaHCO3 (w/v), and 1 mg/mL TPCK-treated trypsin.
After 72 hours, the overlay was removed, and the cells were
washed with 16 sterile PBS, fixed by incubation with cold
methanol/acteone (60:40%), and stained with crystal violet.
Statistics
Statistical significance was determined by Student’s T test using
Prism 5 software (GraphPad Software). Significance was deter-
mined to be any p-value where p,0.05.
Results
NK cells expressing the IL-15 receptor accumulate in the
lung airways of influenza-infected animals
We and others have shown that following influenza infection,
IL-15 message and protein is increased in the lung airways [19,27].
Because this IL-15 expression was rapidly induced by influenza
infection and reached significant levels as early as day 3 post
infection (p.i.) [19], we hypothesized that influenza-induced IL-15
expression may be an important mediator of NK cell responses to
influenza infection. We therefore first sought to determine whether
NK cells responding to influenza infection were capable of
receiving signals from this locally produced IL-15. To this end,
lymphocytes were isolated from the lung airways of influenza-
infected animals via BAL, and CD3
2, NK1.1
+ NK cells were
analyzed for the expression of IL-15 receptor components by flow
cytometry. The IL-15 receptor is a heterotrimer, consisting of the
common gamma chain (CD132), the shared IL-2/IL-15Rb chain
(CD122), and the specific IL-15Ra chain [28]. To date the
majority of biological effects of IL-15 on NK cells, however, are
mediated through the paired co-expression of CD122 and CD132
[29,30,31], while IL-15Ra is only required by accessory cells
which present IL-15 to respondent cells, a mechanism referred to
as trans-presentation [32]. However, some groups have suggested
that IL-15Ra expression alone contains some signaling moieties
which may participate in distinct biological functions [27].
Therefore it is important to establish the kinetics of IL-15 receptor
component expression and IL-15 signaling potential on NK cells
in our model.
NK cells are known to respond rapidly to influenza infection
and continue accumulating in the lung airways through day 5 p.i.
([13] and data not shown). Since we wished to specifically evaluate
recent NK cell immigrants responding to the airway inflammation
resulting from influenza infection, we restricted our analyses of
NK cell kinetics to before and up to day 4 p.i.. NK cells were first
detected in the BAL at day 2 post influenza infection (albeit at a
low frequency, ,0.1–0.6% of lymphocytes, Figure 1A and
Figure 2A) but were completely absent in control mock-infected
animals (data not shown). Despite the low frequency of NK cells in
the lung airway at this early time point, one fifth consistently
expressed IL-15Ra. Additionally, 30–40% of them expressed
CD122 and CD132 (Figure 1B). By day 3 p.i., when NK cells
represented a much more discernible population (,2–3% of
lymphocytes, Figure 1A & 2A), greater than 90% of these gated
cells expressed CD122 and CD132, and expression levels of these
receptors on a per-cell basis increased over time as indicated by a
higher median fluorescence intensity by day 4 p.i. (Figure 1B) and
consistent with evidence that expression of IL-15R components is
induced by activating stimuli [33]. Expression of IL-15Ra
however, was variable but consistently much lower that the
expression levels of CD122 and CD132. This biased expression of
CD122/132 receptor chains over IL-15Ra and enhanced IL-15
levels [19] following influenza infection, indicate that NK cells
accumulating at the site of influenza infection are capable of
responding to locally produced IL-15 via the trans-presentation
pathway.
IL-15 blockade results in reduced numbers of NK cells at
the site of infection and impairs early viral control
Since co-expression of CD122 and CD132 render NK cells
responsive to IL-15 signals, we next wished to determine whether
virally induced IL-15 and subsequent signaling through these
receptors affected the accumulation of these cells in the respiratory
tract. Because IL-15
2/2 mice exhibit a severe developmental
defect in both NK and NKT cell lineages and are nearly devoid of
these cell populations [20], we chose to use an anti-IL-15 blocking
antibody to selectively deplete IL-15 concurrent with infection.
Therefore, we monitored the influx of NK cells in animals
receiving either PBS or anti-IL-15 mAb administered i.p. daily
from day 0 through day 4 post influenza infection. In order to
more accurately define bona fide NK cells, particularly in the lung
airways harboring few NK cells at very early time points post
influenza infection, we included NKp46 reactivity in our staining
protocol and henceforth define NK cells as CD3
2 lymphocytes
positive for both NK1.1 and NKp46. While NK cells accumulated
in the lung airways of untreated mice as expected, by day 2 p.i. the
overall frequency of NK cells in IL-15 blocked animals was
reduced by half and remained this low through day 4 p.i.
(Figure 2A). Concordantly, total numbers of NK cells in IL-15-
blocked mice were partially reduced at day 2 p.i., and substantially
Figure 1. NK cells expressing IL-15 receptor accumulate in the
lung airways of influenza-infected animals. Lymphocytes were
isolated from the BAL of animals infected with 10
3 pfu HKx31i.n. at the
indicated time points post infection. (A) Representative flow plots of NK
1.1
+, CD3
2 cells accumulating in the BAL over time. (B) Expression of IL-
15Ra, CD122, and CD132 on NK cells is shown compared to either
incubation with the secondary streptavidin alone (for IL-15Ra)o ra
fluorescence minus one (FMO) control (for CD122 and CD132
expression) (shaded histograms) for each time point p.i. (n=3 mice).
Number in the upper right hand corner represents median fluorescence
intensity. Data are representative of two independent experiments.
doi:10.1371/journal.pone.0037539.g001
IL-15 Regulated NK Cell Responses
PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e37539Figure 2. Absence of IL-15 selectively reduces the accumulation of NK cells at the site of infection, which impairs early viral control.
Representative flow plots depicting the mean frequency and graphs depicting the mean number 6 SEM of CD3
2, NK1.1
+ NKp46
+ NK cells in PBS
control (solid lines) or aIL-15-treated (dashed lines) mice recovered from the BAL (A), lung (B), and spleen (C) is plotted over time following i.n.
infection with 10
3 pfu HKx31 (n=3 mice/group; *p=0.032 and 0.0145). Data are representative of three independent experiments. (D) Mean number
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numbers of NK cells continued to accumulate in the lung airways
of control-treated animals through day 4 p.i., numbers of NK cells
in the lung airways of treated animals plateaued by day 3 p.i.
(Figure 2A). In the lung parenchyma of control-treated animals,
NK cells also accumulated over time post infection, similar to
those in the lung airways, but the frequencies of NK cells in this
site remained unchanged in IL-15-blocked mice. Numbers of NK
cells in the lung parenchyma of anti-IL-15 treated animals also
remained similar to control animals with only a slight reduction at
day 2 p.i. (Figure 2B). Importantly, while the numbers of NK cells
were significantly reduced at the site of infection as a result of an
IL-15 deficiency, anti-IL-15 treatment had little effect on the
frequency or number of NK cells found in anatomical sites distal to
the site of infection such as the spleen (Figure 2C). In order to
determine whether an absence of IL-15 in the lung airways
resulted in the reduced frequencies and numbers of NK cells
specifically, numbers of other populations of innate cells in the
airways at these early time points post infection were analyzed.
CD11c
2CD11b
+ cells (granulocytes) or CD11c
+CD11b
2 (den-
dritic cells) in the airways following infection were mostly
unaffected by the IL-15 deficiency, with only a small reduction
observed at day 4 p.i. (Figure 2D). In contrast, NK1.1
+CD3
+
(NKT cells) were markedly reduced in the lung airways of IL-15-
blocked mice (Figure 2D), but overall, these cells represented a low
proportion of the innate cells responding to influenza infection at
these early time points following infection (Figure 1A). Together,
these data indicated that short term blockade of IL-15 did not
result in global defects in NK cell homeostasis or survival in
peripheral tissues and the effects of IL-15 were largely specific to
NK cells as blocking IL-15 selectively resulted in a significant loss
of NK cells recovered from the site of infection.
To test whether this local reduction in NK cells impairs the
control of viral replication, we performed plaque assays on
control- and anti-IL-15 treated mice to quantify viral load in the
lungs of animals with intact or diminished IL-15 and NK cell
responses. Viral load was quantified on days 1–5 and 7–8 p.i. to
specifically look at control during the time frame of NK cell entry
and accumulation in the lung airways and the kinetics of
subsequent viral clearance. In IL-15 blocked animals, differences
in viral load were apparent as early as d2 p.i. where viral titers
were about 36 higher through day 3 p.i. (Figure 2E); however,
these animals seemed to regain control of viral replication by day 4
p.i., which perhaps corresponds with the early entry of cells of the
adaptive immune response as anti-influenza specific CD8 T cells
are first detectable in the lung airways by d6 post infection by flow
cytometry ([34] and data not shown). Thus, while viral elimination
is not ultimately dependent on IL-15, early control of the virus is
impaired in the absence of IL-15, which correlates with the arrival
of a significant number of NK cells in the lung airways. We thus
hypothesized that IL-15 was important for the migration of NK
cells in the lung airways following influenza infection.
Administration of exogenous IL-15 enhances the number
of NK cells in the lung airways
We observed significant reductions in the numbers of NK cells
in the lung airways of influenza-infected animals in which IL-15
was blocked at time points associated with their arrival at the site
of infection, and failure of these cell populations to accumulate had
implications in early viral control (Figure 2). In order to determine
whether IL-15 might be an important signal for NK cells in the
migration to and/or the proliferation within the site of infection,
we chose to provide exogenous IL-15 in an attempt to enhance
any IL-15-dependent NK cell migration and/or in situ prolifer-
ation within the lung airways of influenza-infected animals. To this
end, either PBS or recombinant IL-15/IL-15Ra fusion protein
complexes (IL-15c) were administered intranasally to mice three
days following influenza infection. To ensure that any biological
effects of the IL-15c could be attributed to activity of the cytokine
(which is merely stabilized by complexing to IL-15Ra), a control
group of mice received the IL-15Ra only. Concurrent with
treatment, mice received an i.p. pulse of the thymidine analog
BrdU to identify proliferating cells. Twelve hours post treatment,
the frequency and total number of NK cells in the BAL was
quantified as well as the percentage of these cells incorporating
BrdU. Isolated cells were simultaneously stained with 7-AAD as an
indicator of cell viability, as only cells with disrupted membranes
stain positive for this fluorescent dye. Importantly, neither the IL-
15Ra alone nor the IL-15c affected cell viability, as cells isolated
from animals receiving these treatments had similar percentages of
7-AAD
+ NK cells as those from PBS-treated mice (data not
shown).
Upon introduction of IL-15c to the lung airways, the overall
frequency of NK cells isolated from the BAL was significantly
increased (Figure 3A and B), and the total number of NK cells
isolated from this site was nearly three times that of PBS-treated
control animals (Figure 3B). Interestingly, the percentage of NK
cells expressing CD122, the IL-2/15 Rb chain, was reduced in IL-
15c-treated animals (Figure 3B), perhaps indicative of increased
signaling through and subsequent internalization of this receptor
complex by IL-15 responsive cells. Unlike T cells, which require
large clonal bursts of proliferation to achieve effector status, the
effector function of NK cells is more related to activation and
mobilization to the site of inflammation [35]. Nevertheless, we
wished to test whether the large increases in NK cell number in the
lung airways following IL-15c administration could be attributed
to IL-15-induced proliferation of NK cells at the site. To assess the
potential role of proliferation in this observed increase in NK cell
frequency and number in the BAL of treated mice, these NK cells
were analyzed for BrdU incorporation. Concomitantly, cells
isolated from the BAL were assessed for expression of the cell-
cycle-specific protein Ki-67. Since BrdU is incorporated into the
DNA of only cells in S phase whereas Ki-67 is expressed by cells in
any stage of the cell cycle, it was unsurprising that BrdU
+ cells
were only a fraction of Ki-67
+ cells (Figure 3A). Therefore, we
considered only cells positive for both markers as cells undergoing
proliferation at the time of treatment. Although the percentage of
BrdU-incorporating cells was modestly increased in IL-15c-treated
animals, the overall frequency of proliferating cells was low in
untreated (,10%) and treated (,12%) animals (Figure 3B). These
data suggest that IL-15c may trigger the proliferation of NK cells,
but proliferation of this cell population in the lung airways is, in
general, low and not likely to be solely responsible for the total
number of cells extracted from the lung airways. IL-15Ra alone
had no significant impact on the accumulation or proliferation of
this cell population (Figure 3A and B). Finally, differences in cell
of CD11c
2 CD11b
+ cells, CD11c
+ CD11b
2 cells, and CD3
+ NK1.1
+ cells from BAL are shown 6 SEM in PBS control (solid lines) or aIL-15-treated (dashed
lines) mice (n=3 mice/group). (E) At the indicated times p.i. with 10
3 pfu HKx31, lung viral titers from PBS and aIL-15-treated mice were determined
by plaque assay. Mean viral titer is plotted 6 SEM (n=2 mice/group on days 1 and 5 p.i. or 3 mice/group for remaining time points; day 2 p=0.0503).
Data are representative of two independent experiments.
doi:10.1371/journal.pone.0037539.g002
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were specific to the lung airways (the sight of treatment), as NK
cells isolated from spleens were similar in control and IL-15c-
treated animals (Figure 3C and data not shown). Together, these
data demonstrate that exogenous IL-15 results in increased
numbers of NK cells in the lung airways. Since this increase
appeared to be independent of IL-15-mediated effects on cell
survival, and proliferation was low, we hypothesized that IL-15
may be responsible for a substantial amount of migration of NK
cells into the lung airways following influenza infection similar to
its effects on CD8 T cells [19].
NK cells migrate to IL-15c in vitro
Intranasal administration of IL-15c resulted in increased
numbers of NK cells in the lung airways that appeared to be
due to increased migration into that site. Previous studies have
indicated that IL-15 is indeed chemotactic for NK cells. In vitro
checkerboard assays revealed that freshly isolated NK cells
migrated to IL-15 gradients, and IL-15 stimulation increased
LFA-1-dependent binding of NK cells to cultured endothelial cells
[25]. IL-15 has also been shown to play a central role in the
recruitment of CD16
2 human NK cells into the endometrium
following ovulation [36]. To test the direct chemotactic potential
of IL-15c for NK cells in our own system, we employed an in vitro
chemotaxis transwell assay. Bulk lymphocytes (or purified splenic
NK cells, data not shown) from the BAL, lung, and spleen of mice
collected three days after infection with influenza were placed in
the top chamber of a transwell filter support with either media
alone or media supplemented with IL-15c in the bottom chamber.
After 90 minutes of incubation, IL-15c significantly enriched NK
cells isolated from the lung and spleen (Figure 4A). Consistent with
our findings with CD8 T cells [19], NK cells from the lung airways
did not migrate to IL-15c, perhaps because this site represents the
terminal destination for these cell populations. Unlike CD8 T cells,
which lose expression of CD122 upon residence in the lung
airways following influenza infection [19] [37], nearly 100% of the
NK cells residing in the BAL of influenza-infected mice express
CD122 (Figure 1A and B). Nonetheless, these data indicate that
NK cells in the lung parenchyma or the general circulation (as
represented by the spleen) migrate to IL-15 in vitro.
Figure 3. Administration of IL-15c i.n. increases the number of NK cells recovered from the lung airways. On day 3 p.i. with 10
3 pfu
HKx31, mice were administered either PBS vehicle control (black bars), IL-15Ra alone (shaded bars) or IL-15c (open bars) intranasally. Twelve hours
post treatment, CD3
2 lymphocytes were analyzed for NK1.1 and NKp46 expression. These NK cells were quantified and analyzed for CD122
expression, BrdU incorporation, and Ki-67 staining. Representative flow plots are depicted in panel (A), and graphical representations of mean
frequencies and numbers of NK cells 6 SEM, as well as percentage of these cells positive for CD122 and BrdU are depicted in panel (B) (n=3 mice/
group; *=p,0.025). (C) Mean frequencies and numbers of NK cells in the spleen are plotted 6 SEM (n=3 mice/group). Data are representative of
two independent experiments.
doi:10.1371/journal.pone.0037539.g003
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phase enhances early viral control
A temporal cessation in IL-15 bioavailability reduced the
numbers of NK cells (Figure 2A) in the respiratory tract resulting
in increased viral titers (Figure 2E), presumably due to impaired
NK cell responses. Conversely, exogenous IL-15c promoted the
migration of NK cells (Figure 4) and resulted in increased numbers
of NK cells in the lung airways (Figure 3B). We therefore
hypothesized that intranasal administration of IL-15c early after
infection could be used to enhance the early innate immune
response to influenza and augment viral control. To this end,
influenza-infected animals received either PBS or IL-15c intrana-
sally on days 1–4 p.i., a time frame corresponding to the migration
of NK cells into the lung airways and limiting any confounding
effects IL-15c might have on adaptive immune cells entering the
lung airways at later time points. Every other day, from day 2–8
p.i., whole lungs were collected and viral titers were quantified via
plaque assay (Figure 5A). Early (d2) p.i., we observed no difference
in viral load between PBS and IL-15c-treated mice, but as viral
replication reached more significant levels at day 4 p.i., animals
receiving the IL-15c had 2.46 less viral load than animals
receiving only PBS (Figure 5B and C). Although viral titers
dropped 10 fold in both groups of animals by day 6 p.i., as
expected, surprisingly, there remained a greater than 2 fold
significant difference in viral load (Figure 5B and D). Although
both groups of animals cleared the influenza virus completely by
day 8 p.i. (Figure 5B), our data suggest administration of IL-15c on
days 1–4 p.i. can enhance early control of influenza virus by cells
of the innate immune system.
NK cell responses to influenza are requisite for the
optimal accumulation of antigen-specific CD8 T cells at
the site of infection
Because we have previously reported that IL-15 is important for
the migration of influenza-specific CD8 T cells into the lung
airways [19], it was possible that those observed effects were
secondary to the recruitment of NK cells to the lung. To test
whether the accumulation of NK cells in the lung was required for
the subsequent immigration of influenza-specific CD8 T cells to
the respiratory tract, influenza-infected animals were assayed for
the accumulation of anti-influenza specific CD8 T cells in NK
deficient animals, generated by administration of the aNK1.1
depleting mAb PK136 every other day (Figure 6A). Flow
cytometric analyses of NKp46 expression of day 4 p.i. lymphocytes
isolated from the lung, BAL, spleen, and mediastinal lymph nodes
(MdLN) of aNK1.1-treated animals revealed robust depletion of
NK cells as the number of CD3
2NKp46
+ cells were reduced to
less than one third of those observed in PBS-treated control
animals (Figure 6B and data not shown). On days 6 and 8 p.i., the
numbers of influenza-specific CD8 T cells in these same tissues
were quantified through the identification of cells staining positive
for a tetrameric reagent loaded with the immunodominant peptide
derived from the influenza nucleoprotein (NP). Tetramer positive
CD8 T cells could first be detected in the lung airways at day 6
p.i., and although numbers were low, they were somewhat
reduced in the BAL of PK136-treated mice (Figure 6C). No
reduction in influenza-specific CD8 T cell numbers could be
observed in any other tissue. In fact, CD8 T cells seemed to
accumulate in other tissues of animals depleted of NK1.1-
expressing cells. By day 8 p.i., the frequency of influenza-specific
CD8 T cells in the BAL of PK136-injected animals was less than
half than that of control animals, and the total numbers were
reduced nearly threefold (Figure 6D). Again, this effect was specific
to the lung airways, since frequencies and numbers of NP-
tetramer
+ CD8 T cells were unchanged in other tissues examined
(Figure 6D). Therefore, the largely tissue-specific nature of the
dependence of influenza-specific CD8 T cells on the presence of
NK1.1-expressing cells in the lung airways partially indicates that
lung-resident NK and possibly NKT cells are requisite for the
subsequent migration of influenza-specific CD8 T cells into this
site. These data suggest that IL-15-mediated migration of CD8 T
cells to the lung airways may be, at least partially, an indirect effect
of NK1.1
+ cells moving into the lung airway space in response to
IL-15 and that subsequent tissue remodeling or production of an
intermediate factor is responsible for the subsequent recruitment of
the CD8 T cells. To our knowledge, these data for the first time
describe a role for IL-15 in linking the innate and adaptive
responses to influenza infection necessitating the further inquiry of
IL-15 as a potential vaccine adjuvant.
Discussion
Here, we have demonstrated that NK cells, which accumulate
in the lung airways early after influenza infection, are dependent
on IL-15 for this accumulation and subsequent ability to control
viral load. NK cells in the lung airways express high levels of the
common gamma chain (CD132) and CD122, receptors respon-
sible for imparting IL-15 responsiveness. Since IL-15 is known to
be produced in the lung airways following influenza infection, we
investigated the role of IL-15 in NK cell responses to influenza. In
the absence of IL-15, NK cell frequencies and numbers were
significantly reduced in the BAL, resulting in impaired early
control of influenza virus. Although numbers of CD3
+ NK1.1
+
cells were also substantially reduced following anti IL-15
treatment, it is unclear whether this cell population plays a
relevant role in controlling primary infections with influenza.
While NK cells are thought to be very important participants in
the control of influenza replication, evidence for NKT cells
playing a similar role is more controversial [38]. Models of NKT
cell activation using aGal-Cer revealed enhanced innate responses
to influenza and improved disease outcome [39], but challenge of
CD1d
2/2 mice with influenza led to increased survival, implying
an immuno-regulatory role for NKT cells in this model [40].
Whether or not these cells are critically involved in viral clearance,
in our model, they represent a very small percentage (,1%) of the
Figure 4. IL-15 is chemotactic for NK cells in vitro. Three days
following infection with 10
3 pfu HKx31 i.n., 1610
6 bulk lymphocytes
from the pooled BAL, lung, and spleen of 8 mice were placed in the top
chamber of a transwell with the bottom chamber containing 500 mL
either media alone (black bars) or supplemented with 100 ng IL-15c
(open bars). Mean percent migration of CD3
2, NK1.1
+ NK cells is
depicted 6 SEM (n=3 replicates/group; *p=0.046 and 0.003). Data are
representative of three independent experiments. Significant differenc-
es in migration to media alone or media containing IL-15c are indicated
by stars (*p,0.05).
doi:10.1371/journal.pone.0037539.g004
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infection. Therefore, we believe that an abrogation of virally-
induced IL-15 in the lung airways most dramatically affects
CD3
2, NK1.1, NKp46 double positive NK cells responding
rapidly to infection. By the same principle, exogenous IL-15 could
be used therapeutically to increase NK cell populations in the
BAL—primarily as a result of IL-15-induced migration—to
enhance viral control. Therefore, these combined data indicate
that influenza-induced IL-15 is an important signal for the
migration of NK cells to the lung airways where they help limit
viral replication.
IL-15 is produced by a variety of cell types within and outside of
the immune system, including dendritic cells, monocytes and
macrophages, stromal cells, endothelial cells, and epithelial cells
[41], and pathogenic stimuli are known to induce this expression
above constitutive levels [17,42,43,44]. Although dendritic cells
are known to be an important source of IL-15 at day 6 post
influenza infection [27], it is unclear whether DCs or other cell
types produce IL-15 to facilitate specific immune responses to
influenza. For example, lung epithelial cells constitutively express
IL-15 and IL-15Ra [45], and neutrophils and macrophages can be
a major source of IL-15 that is produced during a variety of lung
inflammatory diseases including sarcoidosis, tuberculosis, bron-
chitis, and asthma [46]. Following influenza infection, the IL-15-
producing cell type(s) is/are still unknown, but influenza-induced
expression of IL-15 is clearly an important regulator of the NK
and CD8 T cell responses to this virus [19].
Not only might there be different cellular sources of IL-15 at
different times after infection, but IL-15 signaling in NK cells
could also be regulated by the context in which IL-15 is presented.
At least one isoform of IL-15 is known to enter the cell secretory
pathway and could therefore be released as a soluble molecule
[47,48]. These data lend the idea that soluble IL-15 could bind
heterotrimeric receptors on NK cells. However, IL-15 is also
known to be transpresented to NK cells, and indeed, this mode of
signaling appears to be most important for IL-15-mediated NK
cell survival [49]. While IL-15Ra is dispensable for NK cell
survival, IL-15Ra is thought to be an important component in
signaling the migration of CD16
2 human NK cells into the
endometrium, since this particular NK cell population expresses
higher levels of this receptor component than CD16
+ NK cells that
do not migrate to IL-15 [36]. In our studies, IL-15Ra was only
expressed on a relatively low proportion of NK cells in the lung
airways of influenza-infected animals (Figure 1). In contrast,
CD122 signaling appears to be important for NK cell migration to
IL-15 as this receptor chain is down regulated on NK cells exposed
to IL-15c in vivo (Figure 3). Thus, we consider it likely that
signaling through IL-15Ra is not essential to IL-15-mediated of
migration of NK cells to the lung airways. Therefore, future work
is needed to identify the IL-15-producing cell population(s) and the
mechanism of migration to this cytokine in order to target this
response for eventual applications in influenza vaccines and
treatments.
A significant finding of our work is that NK cells immigrating
into the lung airways are partially required for substantial
trafficking of influenza-specific effector CD8 T cells to this
location. We found that NK cells are necessary for the optimal
accumulation of antigen-specific CD8 T cells, important effectors
of eventual viral clearance [4,5], at the site of infection, since
depletion of NK1.1-expressing cells resulted in a significant
decrease in the number of influenza-specific CD8 T cells in the
BAL. A subpopulation of CD8 T cells has been shown to express
NK1.1 upon activation [50], and while these cells were detected in
the lung parenchyma of influenza-infected C57Bl/6 mice, they
comprised less than 1% of the NP-tetramer+ CD8 T cells at this
site alone and were never detected in the lung airways. This and
the fact that the reduction of activated, influenza-specific CD8 T
cells was observed only in the lung airways, and only at later time
points post infection lead us to believe that direct depletion of
NK1.1-expressing CD8 T cells cannot account for this reduction
Figure 5. Intranasal administration of IL-15c during the innate phase of the immune response against influenza improves early
control of viral control. On days 1–4 post infection with 10
3 pfu HKx31 i.n., animals received either PBS vehicle control (Black circles) or IL-15c (red
squares) i.n. (A). Whole lungs were collected and analyzed via plaque assay for viral titer on days 2, 4, 6, and 8 p.i. (B). Significant differences between
control and IL-15c-treated mice were observed on days 4 (C) and 6 (D) p.i. (*p=0.022 and 0.013).
doi:10.1371/journal.pone.0037539.g005
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+ cells in
the lung airways are requisite for the subsequent accumulation of
influenza-specific CD8 T cells in the BAL and implicate IL-15-
mediated NK cell migration into the lung airways as a link
Figure 6. NK1.1+ NK cells are partially required for the subsequent accumulation of influenza-specific CD8 T cell accumulation at
the site of infection. Beginning on the day of infection, mice received i.v. injections of either PBS vehicle control or aNK1.1 (PK136) every other day
until day 6 p.i. (red arrows), and indicated tissues were collected on days 4, 6, and 8 p.i. (A). Mean number NK cells cells on day 4 p.i. in untreated
(black bars) and PK136-treated (open bars) are shown 6 SEM (n=3 mice/group) (B). Mean number of NP-Tet
+ CD8 T cells in the BAL, lung, and spleen
were quantified and depicted 6 SEM on day 6 (C) and day 8 (D) p.i. (n=3 mice/group). Stars indicate statistical significance (*p=0.009). Data are
representative of three independent experiments.
doi:10.1371/journal.pone.0037539.g006
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We currently favor a model in which NK cells migrate directly to
influenza-induced IL-15 in the lung airways, and, CD8 T cell
trafficking, in turn, occurs to both IL-15 directly and to
chemotactic factors produced by NK cells already present at the
site. A positive feedback loop in which NK cells responding to IL-
15 induce further expression of IL-15 by dendritic cells for the
stimulation of CD8 T cells is an additional possibility [51].
Moreover, IL-15 has also been shown to modulate chemokine and
chemokine receptor expression by NK cells and T cells [52,53,54].
As IL-15 deficiencies also cause reductions in CD8 T cell
accumulation in the BAL [19], chemotactic potential of IL-15
for NK cells presented here provides a possible link between IL-
15-mediated effects of both the innate and adaptive immune
responses to influenza infection. Future work will attempt to tease
out the roles of direct and indirect migration of both NK cells and
CD8 T cells to IL-15 following influenza infection.
Regardless of mechanism, IL-15-induced trafficking of lympho-
cytes is an important part of our overall understanding of influenza
immunobiology. The studies presented here emphasize the
importance of IL-15 in mediating the innate response to influenza
via the trafficking of NK cells, as viral titers were not as efficiently
controlled early after infection in IL-15-blocked animals. These
and previous studies also suggest that exogenous IL-15c could be
used to modulate the immune response at both the innate and
adaptive phases. Overall, we believe that IL-15 may be in
important point of eventual immune intervention for treatment of
primary infection and for adjuvanting vaccines.
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